Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation.

Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S, Aggarwal BB. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J Immunol. 2002 Dec 01; 169(11):6490-7.

View in: PubMed

subject areas

Active Transport, Cell Nucleus
Anti-Inflammatory Agents, Non-Steroidal
Base Sequence
Cell Line
Ceramides
Cyclin D1
Cyclooxygenase 2
DNA
Enzyme Inhibitors
Enzyme Precursors
Gene Expression
Hela Cells
Humans
Hydrogen Peroxide
I-kappa B Kinase
Intracellular Signaling Peptides and Proteins
Isoenzymes
Jurkat Cells
Lipopolysaccharides
Matrix Metalloproteinase 9
Membrane Proteins
NF-kappa B
Okadaic Acid
Phosphorylation
Prostaglandin-Endoperoxide Synthases
Protein-Tyrosine Kinases
Stilbenes
Tetradecanoylphorbol Acetate
Transcription Factor RelA
Tumor Necrosis Factor-alpha

authors with profiles

Shishir Shishodia

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support